NeurologyLive® Friday 5 — October 28, 2022


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 28, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Resources for Sleep Disorders

In this NeurologyLive® Peer Exchange, sleep experts C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.

Peer Exchange: Sleep Disorders and Health Conditions: Focus on Insomnia

2: Ocrelizumab Shows No Effect on Pregnancy and Infant Outcomes

Using a cohort of more than 2000 pregnancies, the data, presented at the 2022 ECTRIMS Congress, showed an extremely rare number of major congenital anomalies while on ocrelizumab, as most patients underwent live birth with no issue.

Mind Moments Ep 75: Focusing on the Future of Neurology

3: NeuroVoices: Stuart Silverman, MD, on the Significance of the Phase 3 FENhance Study of BTK Inhibitor Fenebrutinib

In the latest edition of our in-depth Q&A series, the neurologist at Allegheny Health Network’s Neuroscience Institute provided perspective on a new phase 3 trial assessing fenebrutinib, an investigational BTK inhibitor for relapsing multiple sclerosis.

NeuroVoices: George Small, MD, on the Advances in Myasthenia Gravis Treatment Options, Quality of Life

4: Inadequate Sleep Related to Neurocognitive Difficulties for Children With Insomnia

Fan Nils Yang, PhD, postdoctoral researcher, University of Maryland, provides greater detail on the observational cohort study he did with colleagues, where they identified a link between neurocognitive function in children and insomnia.

Patients With Alzheimer Disease Negatively Impacted by the COVID-19 Pandemic

5: Peer Exchange: Health Care Utilization Rates Among Patients With NMOSD

Experts in neurology including Michael Levy, MD, PhD; Mitzi Williams, MD, and others, share their experiences with how patients with NMOSD are utilizing health care, and helping patients achieve optimal care.

Similar Retinal Measurements Observed in Potential NMOSD and Definite NMOSD


Related Videos
Dolores D. Santamaria, MD
 Bruce Cree, MD, PhD, MAS, FAAN
Video 3 - 5 KOLs are featured in "Transitions of Care: Moving Spinal Muscular Atrophy Patients from Pediatric/Adolescent Care to Adult Clinics"
Video 3 - 5 KOLs are featured in "Presentation of Adult Spinal Muscular Atrophy in Clinics"
Fawad Khan, MD, FACNS
Valerie J. Block, PT, DPTSc
© 2024 MJH Life Sciences

All rights reserved.